Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$22.95 0.95 | 4.32%
07/29/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011
Sales 37.78M 24.68M 31.41M
Cost of Sales 0.00 0.00 0.00
Gross Operating Profit 37.78M 24.68M 31.41M
Selling, General, and Administrative Expenses 11.63M 7.16M 6.59M
Research & Development 50.05M 39.89M 40.06M
Operating Income before D & A (EBITDA) -23.90M -22.37M -15.24M
Depreciation & Amortization 1.33M 1.30M 942.00K
Interest Income 0.00 140.00K 244.00K
Other Income - Net -228.00K 0.00 0.00
Special Income / Charges 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -25.46M -23.52M -15.94M
Interest Expense 0.00 6.00K 38.00K
Pre-Tax Income -25.46M -23.53M -15.98M
Income Taxes 1.94M 0.00 0.00
Minority Interest 0.00 0.00 0.00
Net Income From Continuing Operations -26.07M -22.24M -15.03M
Net Income From Discontinued Operations 0.00 0.00 0.00
Net Income From Total Operations -26.07M -22.24M -15.03M
Extraordinary Income/Losses 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00
Total Net Income -26.07M -22.24M -15.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-26.07M -22.24M -15.03M
Preferred Dividends
Net Income Available To Common -26.07M -22.24M -15.03M
Basic EPS from Continuing Ops. -1.93 -1.00 0.00
Basic EPS from Discontinued Ops. 0.00 0.00 0.00
Basic EPS from Total Operations -1.93 -1.00 0.00
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00
Basic EPS, Total -1.93 -1.00 0.00
Basic Normalized Net Income/Share -1.93 -1.00 n.a.
EPS fr Continuing Ops. -1.93 -1.00 0.00
EPS fr Discontinued Ops 0.00 0.00 0.00
EPS fr Total Ops. -1.93 -1.00 0.00
EPS fr Extraord. Inc. 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00
EPS, Total -1.93 -1.00 0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.93 -1.00 n.a.
Dividends Paid per Share 0.00 0.00 0.00

Partner Headlines for OMED

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter